We couldn’t have done Mono 6 without you. We’ve been conducting antiviral drug research for 30 years and, believe me, you are among the greatest of all our subjects. You kept closely in contact with us, made more than 95% of your scheduled visits, and were a pleasure to work with in every way. Those of you who have completed the trial (made Visit 10) have been told which arm you were assigned to—valomaciclovir or placebo. Those who have not yet finished will be told their assignments at Visit 10 after completion of the SF-12 Health Survey questionnaire. I plan to email all of you detailed results as soon as we have them. Meanwhile, please don’t hesitate to contact us if you have any questions or concerns.
Several of you have asked if there might be another follow-up research project to participate in. We’re working on that. Please keep in touch and let us know of any email or address changes so we can stay connected.
And again, thanks a million!
Dr. Hank